Cisplatin Injection, Powder, Lyophilized, For Solution
Product Images NDC 44567-530

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cisplatin (NDC 44567-530). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wg Critical Care, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Cisplatin 50 mg lyophilized powder for injection vial label by WG Critical Care, LLC. The label shows the brand and generic name, dosage form as injection powder lyophilized for solution, intravenous route, along with storage and handling instructions. The NDC number 44567-530 is displayed on the label.*

FDA Label Image

Cisplatin For Injection, Usp 50 mg Label Image (Image 02)

Label for Cisplatin for Injection, USP 50 mg per vial, powder lyophilized for intravenous infusion. Single-dose vial with caution as a cytotoxic agent. Labeler is WG Critical Care, LLC, product NDC 44567-530-01. Includes dosage information, storage instructions, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.